On this page

Desoximetasone

Prescription ANDA TE AB Official labelling
Informational index, not medical advice. Content is reproduced from public FDA and NLM data. Always confirm against the manufacturer's current prescribing information. Report adverse events to FDA MedWatch.

Overview

Brand name
Desoximetasone
Generic name
Desoximetasone
Dosage form
Cream
Route
Topical
Marketing category
ANDA · ANDA
Labeler
Proficient Rx LP
Product type
Human Prescription Drug
DEA schedule
Not scheduled
Active ingredients
2
NDC product codes
14
Packages
31
Data completeness
82% of corroborating sources present

Active ingredients

Source: NDC Directory
Active ingredients and strengths as listed in the NDC Directory.
Ingredient Strength RxCUI Monograph
Desoximetasone .5 mg/g 1376338 View
Desoximetasone 2.5 mg/g 1376338 View

Forms, strengths and routes

Source: NDC Directory
Dosage form
Cream
Route of administration
Topical
Presentations
45

Pharmacologic classes are listed in the class section below.

Pharmacologic class

Source: NDC Directory
Established pharmacologic classes (EPC), mechanisms of action (MoA), chemical structures (CS) and physiologic effects (PE).
Class Type Browse
Corticosteroid Hormone Receptor Agonists [MoA] MoA All 215 members
Corticosteroid [EPC] EPC All 215 members

Regulatory status

Source: Drugs@FDANDC Directory
Application number
076510
Application type
ANDA · Abbreviated New Drug Application
Approval date
July 1, 2003
Sponsor
PADAGIS ISRAEL
Products on application
1
Submissions recorded
1
Products approved under application 076510.
Product Trade name Form Strength Ingredient Status TE Flags
076510-001 DESOXIMETASONE CREAM DESOXIMETASONE Prescription AB

Therapeutic equivalence

Source: Orange Book
TE code
AB
Reference Listed Drug
No
Reference Standard
No

What this rating means: Therapeutically equivalent — bioequivalence demonstrated by in vivo or in vitro testing

Codes beginning with “A” indicate products the FDA considers therapeutically equivalent. Codes beginning with “B” indicate bioequivalence has not been established. See methodology.

Approval history

Source: Drugs@FDA
Most recent submissions on application 076510.
Type No. Action Status Date Review
Original application 1 Approved July 1, 2003 —

Prescribing information

Source: openFDA Drug Labeling

Reproduced verbatim from the Structured Product Labeling submitted to the FDA (effective 20260511). This is the manufacturer's labelling text, not a summary and not advice.

HUMAN PRESCRIPTION DRUG · 20260511 HUMAN PRESCRIPTION DRUG · 20260507 HUMAN PRESCRIPTION DRUG · 20260501 HUMAN PRESCRIPTION DRUG · 20250702

Indications and Usage

openFDA Drug Labeling

INDICATIONS AND USAGE Desoximetasone cream USP, 0.05%, desoximetasone cream USP, 0.25%, and desoximetasone gel USP, 0.05% are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Dosage and Administration

openFDA Drug Labeling

DOSAGE AND ADMINISTRATION Apply a thin film of desoximetasone cream USP, 0.05%, desoximetasone cream USP, 0.25%, or desoximetasone gel USP, 0.05% to the affected skin areas twice daily. Rub in gently.

Contraindications

openFDA Drug Labeling

CONTRAINDICATIONS Desoximetasone cream USP, 0.05%, desoximetasone cream USP, 0.25%, and desoximetasone gel USP, 0.05% are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Warnings and Cautions

openFDA Drug Labeling

WARNINGS Keep out of reach of children.

WARNINGS Desoximetasone Cream USP, 0.25% is not for ophthalmic use. Keep out of reach of children.

Adverse Reactions

openFDA Drug Labeling

ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria. In controlled clinical studies the incidence of adverse reactions were low (0.8%) for desoximetasone cream USP, 0.25%, and included burning, folliculitis, and folliculo-pustular lesions. The incidence of adverse reactions were also 0.8% for desoximetasone cream USP, 0.05% and included pruritus, erythema, vesiculation, and burning sensation. The incidence of adverse reactions for desoximetasone gel USP, 0.05% was 0.3% with one subject reporting stinging and burning at the site of application.

Description

openFDA Drug Labeling

DESCRIPTION Desoximetasone cream USP, 0.05%, desoximetasone cream USP, 0.25%, and desoximetasone gel USP, 0.05% contain the active synthetic corticosteroid desoximetasone. The topical corticosteroids constitute a class of primarily synthetic steroids used as anti-inflammatory and antipruritic agents. Each gram of desoximetasone cream USP, 0.05% contains 0.5 mg of desoximetasone in an emollient cream base consisting of cetostearyl alcohol, edetate disodium, isopropyl myristate, lanolin alcohol, mineral oil, purified water, and white petrolatum. Each gram of desoximetasone cream USP, 0.25% contains 2.5 mg of desoximetasone in an emollient cream base consisting of cetostearyl alcohol, isopropyl myristate, lanolin alcohol, mineral oil, purified water, and white petrolatum. Each gram of desoximetasone gel USP, 0.05% contains 0.5 mg of desoximetasone in a gel base consisting of carbomer 940, docusate sodium, edetate disodium, isopropyl myristate, purified water, SDAG-3 95% alcohol, and trolamine. The chemical name of desoximetasone is Pregna-1, 4-diene-3, 20-dione, 9-fluoro-11, 21-dihydroxy-16-methyl-,(11ß,16α)-. Desoximetasone has the molecular formula C 22 H 29 FO 4 and a molecular weight of 376.47. The CAS Registry Number is 382-67-2. The structural formula is: Chemical Structure

OVERDOSAGE Topically applied corticosteroids can be absorbed in sufficient amounts to produce systemic effects ( see PRECAUTIONS ).

How Supplied / Storage and Handling

openFDA Drug Labeling

HOW SUPPLIED Desoximetasone cream USP, 0.05% is supplied in: 15 gram (NDC 51672-1271-1), 30 gram (NDC 51672-1271-2), 60 gram (NDC 51672-1271-3), and 100 gram (NDC 51672-1271-7) tubes. Desoximetasone cream USP, 0.25% is supplied in: 15 gram (NDC 51672-1270-1), 30 gram (NDC 51672-1270-2), 60 gram (NDC 51672-1270-3), and 100 gram (NDC 51672-1270-7) tubes. Desoximetasone gel USP, 0.05% is supplied in: 15 gram (NDC 51672-1261-1), 30 gram (NDC 51672-1261-2) and 60 gram (NDC 51672-1261-3) tubes. Store at controlled room temperature between 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature]

Adverse event reports

Source: openFDA FAERS
18,942
FAERS reports mentioning this drug
as of 2026-09-25T03:42:24+00:00
A report count is not a risk measure. FAERS accepts voluntary and mandatory reports without establishing causation, and reporting is influenced by how widely a drug is used, how long it has been marketed, and media attention. FDA states that reports “do not prove that the drug caused the event”. Compare rates, not totals.

Attributed to this product's most-reported active ingredient: DESOXIMETASONE. Combination products with more than six active ingredients are not attributed, because a report count summed across a long ingredient list measures the list, not the medicine.

Packaging and NDCs

Source: NDC Directory
Every National Drug Code package associated with this medication. The NDC is the identifier used for dispensing, billing and pharmacovigilance in the United States.
Package NDC Product NDC Labeler Description Marketing start
50090-0597-0 50090-0597 A-S Medication Solutions 1 TUBE in 1 CARTON (50090-0597-0) / 15 g in 1 TUBE November 28, 2014
50090-5571-0 50090-5571 A-S Medication Solutions 1 TUBE in 1 CARTON (50090-5571-0) / 15 g in 1 TUBE June 25, 2021
72162-2330-2 72162-2330 Bryant Ranch Prepack 1 TUBE in 1 CARTON (72162-2330-2) / 15 g in 1 TUBE June 18, 2024
68180-949-02 68180-949 Lupin Pharmaceuticals, Inc. 1 TUBE in 1 CARTON (68180-949-02) / 60 g in 1 TUBE June 20, 2017
68180-949-04 68180-949 Lupin Pharmaceuticals, Inc. 1 TUBE in 1 CARTON (68180-949-04) / 100 g in 1 TUBE June 20, 2017
68180-950-01 68180-950 Lupin Pharmaceuticals, Inc. 1 TUBE in 1 CARTON (68180-950-01) / 15 g in 1 TUBE June 20, 2017
68180-950-02 68180-950 Lupin Pharmaceuticals, Inc. 1 TUBE in 1 CARTON (68180-950-02) / 60 g in 1 TUBE June 20, 2017
68180-950-04 68180-950 Lupin Pharmaceuticals, Inc. 1 TUBE in 1 CARTON (68180-950-04) / 100 g in 1 TUBE June 20, 2017
45802-495-35 45802-495 Padagis Israel Pharmaceuticals Ltd 1 TUBE in 1 CARTON (45802-495-35) / 15 g in 1 TUBE November 16, 2006
45802-495-37 45802-495 Padagis Israel Pharmaceuticals Ltd 1 TUBE in 1 CARTON (45802-495-37) / 60 g in 1 TUBE October 24, 2006
63187-646-15 63187-646 Proficient Rx LP 1 TUBE in 1 CARTON (63187-646-15) / 15 g in 1 TUBE December 1, 2018
63187-646-60 63187-646 Proficient Rx LP 1 TUBE in 1 CARTON (63187-646-60) / 60 g in 1 TUBE December 1, 2018
71205-271-15 71205-271 Proficient Rx LP 1 TUBE in 1 CARTON (71205-271-15) / 15 g in 1 TUBE May 1, 2019
71656-086-15 71656-086 Saptalis Pharmaceuticals, LLC. 15 TUBE in 1 CARTON (71656-086-15) / 15 g in 1 TUBE April 13, 2026
71656-086-60 71656-086 Saptalis Pharmaceuticals, LLC. 60 TUBE in 1 CARTON (71656-086-60) / 60 g in 1 TUBE April 13, 2026
71656-087-15 71656-087 Saptalis Pharmaceuticals, LLC. 15 TUBE in 1 CARTON (71656-087-15) / 15 g in 1 TUBE May 7, 2026
71656-087-60 71656-087 Saptalis Pharmaceuticals, LLC. 60 TUBE in 1 CARTON (71656-087-60) / 60 g in 1 TUBE May 7, 2026
51672-1270-1 51672-1270 Sun Pharmaceutical Industries, Inc. 1 TUBE in 1 CARTON (51672-1270-1) / 15 g in 1 TUBE November 30, 1990
51672-1270-2 51672-1270 Sun Pharmaceutical Industries, Inc. 1 TUBE in 1 CARTON (51672-1270-2) / 30 g in 1 TUBE November 30, 1990
51672-1270-3 51672-1270 Sun Pharmaceutical Industries, Inc. 1 TUBE in 1 CARTON (51672-1270-3) / 60 g in 1 TUBE November 30, 1990
51672-1270-7 51672-1270 Sun Pharmaceutical Industries, Inc. 1 TUBE in 1 CARTON (51672-1270-7) / 100 g in 1 TUBE November 30, 1990
51672-1271-1 51672-1271 Sun Pharmaceutical Industries, Inc. 1 TUBE in 1 CARTON (51672-1271-1) / 15 g in 1 TUBE November 30, 1990
51672-1271-2 51672-1271 Sun Pharmaceutical Industries, Inc. 1 TUBE in 1 CARTON (51672-1271-2) / 30 g in 1 TUBE November 30, 1990
51672-1271-3 51672-1271 Sun Pharmaceutical Industries, Inc. 1 TUBE in 1 CARTON (51672-1271-3) / 60 g in 1 TUBE November 30, 1990
51672-1271-7 51672-1271 Sun Pharmaceutical Industries, Inc. 1 TUBE in 1 CARTON (51672-1271-7) / 100 g in 1 TUBE November 30, 1990
72578-091-01 72578-091 Viona Pharmaceuticals Inc 1 TUBE in 1 CARTON (72578-091-01) / 15 g in 1 TUBE August 31, 2020
72578-091-02 72578-091 Viona Pharmaceuticals Inc 1 TUBE in 1 CARTON (72578-091-02) / 60 g in 1 TUBE August 31, 2020
72578-091-03 72578-091 Viona Pharmaceuticals Inc 1 TUBE in 1 CARTON (72578-091-03) / 100 g in 1 TUBE August 31, 2020
70771-1437-0 70771-1437 Zydus Lifesciences Limited 1 TUBE in 1 CARTON (70771-1437-0) / 100 g in 1 TUBE February 12, 2019
70771-1437-1 70771-1437 Zydus Lifesciences Limited 1 TUBE in 1 CARTON (70771-1437-1) / 15 g in 1 TUBE February 12, 2019
70771-1437-3 70771-1437 Zydus Lifesciences Limited 1 TUBE in 1 CARTON (70771-1437-3) / 60 g in 1 TUBE February 12, 2019
50090-0597 50090-0597 A-S Medication Solutions — October 24, 2006
50090-5571 50090-5571 A-S Medication Solutions — November 30, 1990
72162-2330 72162-2330 Bryant Ranch Prepack — October 24, 2006
68180-949 68180-949 Lupin Pharmaceuticals, Inc. — June 20, 2017
68180-950 68180-950 Lupin Pharmaceuticals, Inc. — June 20, 2017
45802-495 45802-495 Padagis Israel Pharmaceuticals Ltd — October 24, 2006
63187-646 63187-646 Proficient Rx LP — October 24, 2006
71205-271 71205-271 Proficient Rx LP — March 31, 2016
71656-086 71656-086 Saptalis Pharmaceuticals, LLC. — April 13, 2026
71656-087 71656-087 Saptalis Pharmaceuticals, LLC. — May 7, 2026
51672-1270 51672-1270 Sun Pharmaceutical Industries, Inc. — November 30, 1990
51672-1271 51672-1271 Sun Pharmaceutical Industries, Inc. — November 30, 1990
72578-091 72578-091 Viona Pharmaceuticals Inc — August 31, 2020
70771-1437 70771-1437 Zydus Lifesciences Limited — February 12, 2019

Sources for this page

Every dataset that contributed a fact to this page.
Dataset Agency Used for
NDC Directory FDA Identity, ingredients, strengths, forms, routes, labelers, packages
Drugs@FDA FDA Application, sponsor, submissions, review documents, marketing status
Orange Book FDA Therapeutic equivalence codes, reference drug flags, patents, exclusivity
Drug Labeling FDA / NLM Prescribing information reproduced above
FAERS FDA Adverse event report counts

Generated September 25, 2026 · 12 sections on this page.